Publikationen von L. Hoeijmakers

Hartmann, J.; Dedic, N.; Pöhlmann, M. L.; Häusl, A.; Karst, H.; Engelhardt, C.; Westerholz, S.; Wagner, K. V.; Labermaier, C.; Hoeijmakers, L. et al.; Kertokarijo, M.; Chen, A.; Joeels, M.; Deussing, J. M.; Schmidt, M. V.: Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor. MOLECULAR PSYCHIATRY 22 (3), S. 466 - 475 (2017)

Gassen, N. C.; Fries, G. R.; Zannas, A. S.; Hartmann, J.; Zschocke, J.; Hafner, K.; Carrillo-Roa, T.; Steinbacher, J.; Preißinger, S. N.; Hoeijmakers, L. et al.; Knop, M.; Weber, F.; Kloiber, S.; Lucae, S.; Chrousos, G. P.; Carell, T.; Ising, M.; Binder, E. B.; Schmidt, M. V.; Ruegg, J.; Rein, T.: Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Science signaling 8 (404), S. ra119 - ra119 (2015)

Hartmann, J.; Wagner, K. V.; Gaali, S.; Kirschner, A.; Kozany, C.; Ruhter, G.; Dedic, N.; Häusl, A. S.; Hoeijmakers, L.; Westerholz, S. et al.; Namendorf, C.; Gerlach, T.; Uhr, M.; Chen, A.; Deussing, J. M.; Holsboer, F.; Hausch, F.; Schmidt, M. V.: Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties. The Journal of neuroscience: the official journal of the Society for Neuroscience 35 (24), S. 9007 - 16 (2015)

Hoeijmakers, L.; Harbich, D.; Schmid, B.; Lucassen, P. J.; Wagner, K. V.; Schmidt, M. V.; Hartmann, J.: Depletion of FKBP51 in Female Mice Shapes HPA Axis Activity. PLOS ONE 9 (4), e95796 (2014)

Hartmann, J.; Dedic, N.; Wagner, K. V.; Hoeijmakers, L.; Müller, M. B.; Holsboer, F.; Schmidt, M. V.: FKBP5 Critically Impacts Antidepressant Action and Recovery from Chronic Stress. In BIOLOGICAL PSYCHIATRY, 75 (9), S. 311S - 311S. 69th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry, New York, NY. Elsevier Science Inc., New York, NY, USA (2014)